FDA inspection
Aurobindo Pharma Limited: FDA inspection ending Jul 18, 2019
FDA inspection 1097941 · Voluntary Action Indicated (VAI) · Visakhapatnam
Key facts
| Inspection ID | 1097941 |
|---|---|
| Firm | Aurobindo Pharma Limited |
| FEI number | 3014477031 |
| Address | Unit-Xiv, Plot No 17, E-Bonangi (Village) Jawaharlal Nehru Pharma City, Parawada (Mandal) |
| City | Visakhapatnam |
| Fiscal year | 2019 |
| Inspection end date | Jul 18, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data